The findings of a post-hoc analysis conducted using the data from the SELECT-COMPARE trial have shown that the treatment using upadacitinib (UPA) has helped in …
A recent study by Simader et al., published in the Annals of Rheumatic Diseases, has concluded that full two-course immunization against SARS-CoV-2 is important to …
Neuropathic pain (NP), is a disruptive symptom associated with many diseases, which results in restricted physical function, anxiety, and depression. A recent systematic review and …
Glucocorticoids serve as the mainstay of treatment for managing polymyalgia rheumatic treatment. However, longer treatment duration and steroid-related adverse events are the major challenges in …
Abnormal cytokine tumor necrosis factor (TNF) production has been identified as the key pathogenic event responsible for autoimmune tissue inflammation. A recent study published in …
There are no preventive measures for rheumatoid arthritis (RA) and for the past few decades, researchers have been exploring the possibility of having a vaccine. …
The 2021 guidelines published by the American College of Rheumatology (ACR) provide recommendations for deciding on the treatment interventions based on the routine clinical challenges. …
The findings of a double-blind, withdrawal phase III study, published in Lancet, have reported the safety and efficacy of tofacitinib in managing patients with polyarticular …
The introduction of COVID-19 vaccines is a sign of relief amidst of coronavirus pandemic around the world. However, a hesitancy for vaccination has been developed …